MedPath

Automated Hovering for Congestive Heart Failure Patients: A Pilot Study

Not Applicable
Completed
Conditions
Heart Failure
Registration Number
NCT02689687
Lead Sponsor
University of Pennsylvania
Brief Summary

This study offers remote monitoring devices for weight and medication adherence, combined with behavioral economic approaches, to patients with congestive heart failure (CHF). This pilot study aims to evaluate the feasibility of enrollment processes and intervention roll-out to inform a randomized controlled trial, to estimate the readmission rate of participants, and to assess if and how managing clinicians respond to weight gain alerts entered into a participant's electronic medical record.

Detailed Description

The specific aims of this study are: (1) To leverage access to the University of Pennsylvania Health System (UPHS) CHF clinic, PennChart (electronic medical record system) resources for identifying eligible patients, and the Way to Health (WTH) platform to launch a pilot study that will inform a randomized controlled trial; (2) to evaluate the feasibility of the enrollment processes and intervention roll-out to inform a randomized controlled trial; (3) to estimate the readmission rate of participants; and, (4) to assess if and how managing physicians respond to weight gain alerts entered into participant charts in PennChart. In this pilot study, no randomization will occur and all participants will receive the intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Discharged to home within the past 30 days from a UPHS hospital with a principal diagnosis of CHF
  • Aged 18 to 80 years old
  • Will receive follow-up in a UPHS outpatient clinic by a cardiologist or primary care physician
Exclusion Criteria
  • Less than 18 years old or older than 80 years old
  • Will not or cannot provide informed consent
  • Have a markedly shortened life expectancy (listed for heart transplant, have ventricular assist device, are inotrope dependent, have metastatic cancer, or have dementia)
  • Have end-stage renal disease
  • Have a glomerular filtration rate <25 ml/min
  • On dialysis
  • Heart failure is managed with a CardioMEMS monitor
  • Receiving another remote monitoring/telemedicine intervention
  • Receiving follow-up care outside of UPHS

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Number of patients successfully setup on the remote monitoring devices30 days
Secondary Outcome Measures
NameTimeMethod
Proportion of weight gain alerts that are opened30 days
All-cause readmission rate30 days

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.